Cutaneous Lupus Erythematosus - 26 Studies Found

Completed : Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
: Cutaneous Lupus Erythematosus
: 2007-08-30
: Procedure: laser treatment (Candela Vbeam Perfecta™) This laser has an adjustable pulse duration (
Terminated : A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
: Cutaneous Lupus Erythematosus
: 2011-11-09
:
  • Drug: PD-0360324 Subjects will
Completed : Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
: Cutaneous Lupus Erythematosus
: 2006-04-21
: Drug: Tacrolimus ointment
Completed : Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
: Cutaneous Lupus Erythematosus
: 2012-01-10
Completed : IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
: Cutaneous Lupus Erythematosus
: 2013-04-21
: Drug: IVIg All enrolled subjects will receive IVIg treatment following the protocol that proved to be ef
Completed : Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)
: Cutaneous Lupus Erythematosus
: 2010-05-24
: Other: UV A and B irradiation UV irradiation
Completed : Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
: Cutaneous Lupus Erythematosus
: 2012-06-26
: Behavioral: Cutaneous Lupus educational script Subjects will listen to a short informational script on C
Completed : To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
: Cutaneous Lupus Erythematosus
: 2010-10-18
:
  • Drug: CC-11050 Cohort 1: 50 mi
Not yet recruiting : Safety and Efficacy of Filgotinib and GS-9876 in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)
: Cutaneous Lupus Erythematosus
: 2017-04-25
:
  • Drug: Filgotinib 200 mg tablet
Completed : Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
: Subacute Cutaneous Lupus Erythematosus
: 2011-02-10
:
  • Drug: KRP203 - 1.2mg
  • Drug: Placebo to KRP2
Next >>>